November 5, 2007 - According to late-breaking clinical trial results presented at the American Heart Association’s ...
November 5, 2007 – Boston Scientific Corp. highlighted at the American Heart Association conference its new Stentplus ...
November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER sirolimus-eluting coronary stent continued to provide clinical benefits with similar safety compared to a bare metal stent at five-year follow-up, according to data presented at the American Heart Association Scientific Session 2007.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 5, 2007 - Pinyons Medical Technology announced it received FDA clearance to market the PowrSyringe Injector, a ...
November 4, 2007 - A small, implantable device that helps the heart pump blood works equally well for men and women but ...
November 4, 2007 – A specific way of dosing eptifibatide appears equally effective as giving abciximab as an adjunct to ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 4, 2007 – The antiplatelet drug prasugrel offered greater benefit than current, standard therapy for patients ...
November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart attack than bare metal stents, according to a late-breaking outcomes trial presented at the American Heart Association’s Scientific Sessions 2007.
November 4, 2007 - The prevalence of asymptomatic peripheral artery disease (PAD) is steadily increasing among American ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
November 4, 2007 – Single photon emission computed tomography (SPECT) can identify which patients will benefit more from undergoing percutaneous coronary intervention (PCI) than receiving medical therapy alone for blocked coronary arteries, according to late-breaking clinical trial results presented at the American Heart Association’s Scientific Sessions 2007.
ATS Medical Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, received FDA ...
Ovalum Ltd., a privately held Israeli medical device company, has received FDA marketing clearance for the CiTop ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 1, 2007 – Siemens Medical Solutions has just introduced the MAGNETOM Verio, a 3 Tesla (3T) MRI system with a 70 ...
AFP Imaging’s NewTom 3G is an in-office cone-beam CT designed for otolaryngology. The scanner can acquire 360 X-rays in only 36 seconds, and produces — with the aid of primary reconstruction software — a 3D database of the patient’s maxillofacial anatomy.
November 1, 2007 - TeraRecon, a provider of advanced visualization solutions, received the Frost & Sullivan 2007 Market ...